About EIB
The European Investment Bank (EIB) is the long-term lending bank of the European Union, owned by the EU’s 27 Member States, supporting EU policies in over 160 countries around the world. The EIB’s activities focus on climate and the environment, development, innovation and skills, small and medium-sized businesses, including health and life science infrastructure and cohesion. EIB has supported Oncopeptides since October 2020. www.eib.org
The following files are available for download:
| https://mb.cision.com/Main/15404/3671912/1697017.pdf | Oncopeptides enters into a renewed loan facility agreement of up to €30 million with the European Investment Bank |
SOURCE Oncopeptides AB